1. Home
  2. MVSTW vs REVBW Comparison

MVSTW vs REVBW Comparison

Compare MVSTW & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MVSTW
  • REVBW
  • Stock Information
  • Founded
  • MVSTW 2006
  • REVBW N/A
  • Country
  • MVSTW United States
  • REVBW United States
  • Employees
  • MVSTW N/A
  • REVBW 9
  • Industry
  • MVSTW Industrial Machinery/Components
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MVSTW Miscellaneous
  • REVBW Health Care
  • Exchange
  • MVSTW Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • MVSTW N/A
  • REVBW N/A
  • IPO Year
  • MVSTW N/A
  • REVBW 2020
  • Fundamental
  • Price
  • MVSTW $0.38
  • REVBW $0.02
  • Analyst Decision
  • MVSTW
  • REVBW
  • Analyst Count
  • MVSTW 0
  • REVBW 0
  • Target Price
  • MVSTW N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • MVSTW 126.0K
  • REVBW N/A
  • Earning Date
  • MVSTW 03-14-2025
  • REVBW N/A
  • Dividend Yield
  • MVSTW N/A
  • REVBW N/A
  • EPS Growth
  • MVSTW N/A
  • REVBW N/A
  • EPS
  • MVSTW N/A
  • REVBW N/A
  • Revenue
  • MVSTW $370,989,000.00
  • REVBW N/A
  • Revenue This Year
  • MVSTW N/A
  • REVBW N/A
  • Revenue Next Year
  • MVSTW N/A
  • REVBW N/A
  • P/E Ratio
  • MVSTW N/A
  • REVBW N/A
  • Revenue Growth
  • MVSTW 39.03
  • REVBW N/A
  • 52 Week Low
  • MVSTW $0.35
  • REVBW N/A
  • 52 Week High
  • MVSTW $0.44
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • MVSTW N/A
  • REVBW N/A
  • Support Level
  • MVSTW N/A
  • REVBW N/A
  • Resistance Level
  • MVSTW N/A
  • REVBW N/A
  • Average True Range (ATR)
  • MVSTW 0.00
  • REVBW 0.00
  • MACD
  • MVSTW 0.00
  • REVBW 0.00
  • Stochastic Oscillator
  • MVSTW 0.00
  • REVBW 0.00

About MVSTW Microvast Holdings Inc.

Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: